Scientists at St. Jude Children's Research Hospital have built what they describe as the first cell type-specific protein atlas of Alzheimer's disease, using brains from mouse models of the disease. By combining and comparing several kinds of data, the team identified more than 3,000 proteins whose levels change across a range of cell types, and 78% of those changes had not been captured before. The work was published in Neuron.
The team focused on microglia, the immune cells of the brain, because many Alzheimer's risk genes are active in them. Almost all of the changes they found in microglia had gone undetected in earlier studies. The analysis also pointed to a possible communication network between cell types, in which a protein made by one cell type is secreted and acts on another.
The clearest example involved pleiotrophin. The researchers found high RNA levels of this protein in astrocytes, another type of support cell, but high protein levels in microglia. That pattern suggests the protein is made in astrocytes and then secreted to act on microglia, a form of cell-to-cell signaling that bulk analyses of brain tissue would be unlikely to reveal.
The study rests on a method that pairs deep protein profiling with single-cell RNA sequencing and spatial analysis. Co-corresponding author Junmin Peng said the team's lab specializes in deep proteomics, which gave the datasets enough coverage to compare meaningfully with RNA data. Co-author Jiyang Yu said the approach allows researchers to examine specific cellular interactions, such as those between microglia and astrocytes.
The researchers have made the atlas and its datasets publicly available, and they note that it may help other scientists move into single-cell analysis of human Alzheimer's samples. The authors also said the study identifies many potential disease drivers that could be examined in follow-up work. The source describes these as candidates for future study rather than established causes.